As of 2024-12-13, the Relative Valuation of MaxCyte Inc (MXCT.L) is (341.46) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 324.00 GBP, the upside of MaxCyte Inc based on Relative Valuation is -205.4%.
The range of the Relative Valuation is (342.35) - (358.67) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.0x - 20.2x | 18.3x |
| Forward P/E multiples | 19.3x - 20.3x | 20.2x |
| Fair Price | (342.35) - (358.67) | (341.46) |
| Upside | -205.7% - -210.7% | -205.4% |
| Date | P/E |
| 2024-12-09 | -17.76 |
| 2024-12-06 | -15.73 |
| 2024-12-05 | -15.84 |
| 2024-12-04 | -15.84 |
| 2024-12-03 | -15.67 |
| 2024-12-02 | -15.62 |
| 2024-11-29 | -15.50 |
| 2024-11-28 | -15.50 |
| 2024-11-27 | -15.67 |
| 2024-11-26 | -15.33 |
| 2024-11-25 | -16.07 |
| 2024-11-22 | -15.28 |
| 2024-11-21 | -15.00 |
| 2024-11-20 | -14.77 |
| 2024-11-19 | -14.77 |
| 2024-11-18 | -15.05 |
| 2024-11-15 | -15.50 |
| 2024-11-14 | -15.50 |
| 2024-11-13 | -15.22 |
| 2024-11-12 | -15.50 |
| 2024-11-11 | -14.77 |
| 2024-11-08 | -15.28 |
| 2024-11-07 | -15.73 |
| 2024-11-06 | -17.08 |
| 2024-11-05 | -16.29 |
| 2024-11-04 | -16.24 |
| 2024-11-01 | -15.95 |
| 2024-10-31 | -15.73 |
| 2024-10-30 | -15.50 |
| 2024-10-29 | -15.50 |
| 2024-10-28 | -16.07 |
| 2024-10-25 | -16.41 |
| 2024-10-24 | -16.41 |
| 2024-10-23 | -16.41 |
| 2024-10-22 | -16.41 |
| 2024-10-21 | -16.41 |
| 2024-10-18 | -16.46 |
| 2024-10-17 | -16.46 |
| 2024-10-16 | -16.46 |
| 2024-10-15 | -16.46 |
| 2024-10-14 | -16.63 |
| 2024-10-11 | -16.07 |
| 2024-10-10 | -16.41 |
| 2024-10-09 | -15.95 |
| 2024-10-08 | -16.41 |
| 2024-10-07 | -16.18 |
| 2024-10-04 | -16.01 |
| 2024-10-03 | -16.01 |
| 2024-10-02 | -16.01 |
| 2024-10-01 | -16.52 |